NSE
Wednesday, November 11, 2026   
Adani Enterp.  2714.50  (8.20)  
 
Adani Ports  1907.00  (-35.70)  
 
Apollo Hospita...  8604.00  (54.50)  
 
Asian Paints  2550.30  (41.00)  
 
Axis Bank  1336.40  (25.70)  
 
Bajaj Auto  11040.00  (61.00)  
 
Bajaj Finance  1078.80  (13.95)  
 
Bajaj Finserv  1845.00  (8.10)  
 
Bharat Electro...  399.00  (4.45)  
 
Bharti Airtel  2109.00  (36.90)  
 
BSE  3906.00  (89.40)  
 
Cipla  1419.90  (16.10)  
 
Coal India  406.30  (4.80)  
 
Dr Reddy's Lab...  1377.00  (-8.00)  
 
Eicher Motors  7592.00  (-37.00)  
 
Eternal  361.10  (-2.35)  
 
Grasim Inds  3156.70  (-13.00)  
 
HCL Technologi...  1395.00  (-12.00)  
 
HDFC Bank  806.60  (8.45)  
 
HDFC Life Insu...  573.55  (8.15)  
 
Hind. Unilever  2022.40  (32.10)  
 
Hindalco Inds.  962.30  (2.30)  
 
ICICI Bank  1571.60  (-17.40)  
 
Infosys  1155.00  (0.90)  
 
Interglobe Avi...  5665.00  (235.00)  
 
ITC  285.00  (6.20)  
 
Jio Financial  230.60  (0.60)  
 
JSW Steel  1353.30  (6.30)  
 
Kotak Mah. Ban...  487.70  (8.20)  
 
Larsen & Toubr...  4212.00  (27.00)  
 
M & M  3465.00  (174.40)  
 
Maruti Suzuki  13185.00  (257.00)  
 
Max Healthcare  928.30  (13.30)  
 
Nestle India  1288.00  (-9.80)  
 
NTPC  327.00  (-1.75)  
 
O N G C  234.80  (1.30)  
 
Power Grid Cor...  263.75  (5.80)  
 
Reliance Indus...  1335.40  (11.00)  
 
SBI  1061.20  (19.20)  
 
SBI Life Insur...  1767.00  (19.00)  
 
Shriram Financ...  969.15  (4.15)  
 
Sun Pharma.Ind...  1902.30  (-2.20)  
 
Tata Consumer  1093.00  (9.10)  
 
Tata Motors PV...  299.25  (4.25)  
 
Tata Steel  189.28  (4.43)  
 
TCS  2472.10  (-3.30)  
 
Tech Mahindra  1788.50  (-16.50)  
 
Titan Company  4970.00  (-35.00)  
 
Trent  3222.70  (103.50)  
 
UltraTech Cem.  12362.00  (87.00)  
  
BSE
Wednesday, November 11, 2026   
Adani Ports  1907.70  (-32.30)  
 
Asian Paints  2545.95  (44.05)  
 
Axis Bank  1339.00  (28.00)  
 
Bajaj Finance  1075.00  (10.00)  
 
Bajaj Finserv  1855.00  (21.15)  
 
Bharat Electro...  398.50  (4.30)  
 
Bharti Airtel  2107.00  (42.00)  
 
Eternal  360.80  (-2.20)  
 
HCL Technologi...  1393.60  (-13.40)  
 
HDFC Bank  808.70  (12.60)  
 
Hind. Unilever  2020.00  (28.00)  
 
ICICI Bank  1570.00  (-15.00)  
 
Infosys  1153.00  (-0.90)  
 
Interglobe Avi...  5650.35  (236.75)  
 
ITC  284.50  (6.00)  
 
Kotak Mah. Ban...  488.00  (8.00)  
 
Larsen & Toubr...  4207.50  (22.20)  
 
M & M  3456.40  (172.40)  
 
Maruti Suzuki  13179.00  (264.00)  
 
NTPC  326.25  (-2.15)  
 
Power Grid Cor...  263.15  (4.95)  
 
Reliance Indus...  1333.40  (9.50)  
 
SBI  1060.20  (18.75)  
 
Sun Pharma.Ind...  1896.00  (-9.00)  
 
Tata Steel  189.00  (4.10)  
 
TCS  2469.10  (-2.00)  
 
Tech Mahindra  1776.80  (-23.20)  
 
Titan Company  4965.05  (-39.95)  
 
Trent  3209.00  (94.00)  
 
UltraTech Cem.  12433.80  (173.80)  
  

Economy News


Government extends PLI Scheme for Medical Devices
(14:37, 11 Nov 2026)
The Government of India has initiated a new round of applications for the Production Linked Incentive Scheme for Promoting Domestic Manufacturing of Medical Devices (PLI-MD), with the program's duration now extended through 2035–36. An approximate outlay of ?2700 Cr is allocated for the scheme. An online portal for application submissions will be activated within the next 10 days. Introduced in 2020-21, the PLI-MD scheme has spurred the domestic manufacture of more than 60 high-end medical devices and components, encompassing X-ray tubes and detectors, 1.5T MRI, LINAC, CT scanners, mammography machines, Cathlab, orthopaedic and cardiac implants, dialyzers, and others. The initiative has yielded production valued at over ?16,000 crore.

Drawing on insights from the initial phase of the initiative, refinements have been implemented concerning eligibility criteria and the incentive claiming process for applicants. Applicants will have a period of 3 years to establish their manufacturing facilities within any of the 4 Target Segments (TS) namely medical consumables, disposables and implants (TS 1), Critical components (TS2), high-end medical devices currently in the early stages of domestic production (TS3), and high-end medical devices presently only assembled within the country (TS4). The incentive rate will taper.

5% for TS1,

TS2 & TS3 saw a 9% increase, and TS4 registered a 6% gain. Within the Consumables and Disposables segment, efforts will center on establishing manufacturing scale and world-class quality. For TS 3 & 4, emphasis will be placed on value chain integration to enhance overall competitiveness and the quality of Made in India devices. The focus on critical component manufacturing under the Scheme is intended to facilitate value chain integration and provide a stimulus to the MSME sector.

The Scheme’s minimum sales threshold for incentive eligibility has been eliminated, and the minimum investment requirement has been reduced. To improve Ease of Doing Business (EoDB), the scheme guidelines have been streamlined and made more investor-friendly. Applicants may now submit an unlimited number of applications across one or more TS, and the application window will remain continuously open for an extended duration.